AbbVie: Uveitis trials

The registry lists 11 Uveitis studies with AbbVie as lead sponsor. 0 are open to participants now and 4 have results posted.

Phase 2 3Phase 3 5Phase 4 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitisCompletedNCT01148225Phase 3Results posted
• Efficacy and Safety of Adalimumab in Patients With Active UveitisCompletedNCT01138657Phase 3Results posted
• Efficacy and Safety of Adalimumab in Subjects With Inactive UveitisCompletedNCT01124838Phase 3Results posted
• A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior UveitisCompletedNCT00333814Phase 2/3Results posted
• A Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Participants Requiring High Dose Corticosteroids for Active Non-Infectious Intermediate, Posterior, or Pan-UveitisCompletedNCT05414201Phase 4
• Impact of Humira® Therapy on Ocular Inflammation, Selected Health Care Resource Utilization and Patient Reported Outcomes in Patients With Active Non-infectious Intermediate, Posterior and Panuveitis in Routine Clinical PracticeCompletedNCT03155243
• Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the EyeTerminatedNCT02951975
• HUMIRA® Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitisCompletedNCT02916017
• A Long-Term Safety Study of OZURDEX® in Clinical PracticeCompletedNCT01539577
• A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Anterior UveitisTerminatedNCT00333996Phase 2/3
• Research Study in Patients With Persistent Macular EdemaCompletedNCT00035906Phase 2